UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001123
Receipt number R000001371
Scientific Title A phase II study of percutaneous radiofrequency ablation for malignant reanl tumor (JIVROSG-0701)
Date of disclosure of the study information 2008/04/22
Last modified on 2012/03/10 18:56:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A phase II study of percutaneous radiofrequency ablation for malignant reanl tumor (JIVROSG-0701)

Acronym

Percutaneous radiofrequency ablation for malignant renal tumor (JIVROSG-0701)

Scientific Title

A phase II study of percutaneous radiofrequency ablation for malignant reanl tumor (JIVROSG-0701)

Scientific Title:Acronym

Percutaneous radiofrequency ablation for malignant renal tumor (JIVROSG-0701)

Region

Japan


Condition

Condition

malignant renal tumor

Classification by specialty

Medicine in general Cardiology Endocrinology and Metabolism
Hematology and clinical oncology Nephrology Surgery in general
Vascular surgery Endocrine surgery Urology
Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety and efficacy of percutaneous radiofrequency ablation for malignant renal tumor.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Phase I,II


Assessment

Primary outcomes

Adverse events

Key secondary outcomes

Response rate of tumor shrinkage on RECIST


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

A radiofrequency needle is inserted into the renal tumor percutaneously, and then, radiofrequency tumor ablation is performed.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Histologically or imaging confirmed malignant renal tumor.
2) Having at least one target lesion with maximum diameter on CT image between 1.0cm and 3.cm.
3) Target lesion shows the increase of HU more than 20 on CT by contrast enhacement.
4) Surgical treatment is out of indication or refused.
ous loco-regional therapy for the tumor.
5) Adequate cardiac, hepatic, renal, respiratory, coagulation, and bone marrow functions.
6) Age less than 20 at informed consent.
7) Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2.
8) Expected survival more than 2 months.
9) Written informed consent.

Key exclusion criteria

1) Cardiac pacemaker.
2) Artery, nerve or ureter exists on the puncture route.
3) Target lesion adjacent to renal pelvis, or a RFA needle can not be inserted without passing through renal pelvis or alimentary tract.
4) Non-mesurable target lesion on CT.
5) Colinically significant bleeding tendency or abnormal coagulation.
6) Tentative stop of anti-platelet or anti-coagulant medication is not allowed.
7) Drug allergy
8) With active infection
9) With active inflammation
10) Fever above 38 degrees Celsius.
11) If having multiple lesions, no treatment of tumors except a target lesion for 4 weeks after the treatment for a target lesion is not allowed.
12) Stop of chemotherapy or immunotherapy for 4 weeks after the treatment for a target lesion is not allowed.
13) Previous reginal therapy for the target lesion.
14) Pregnancy.

Target sample size

33


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Susumu Kanazawa

Organization

Okayama University

Division name

Department of Radiology

Zip code


Address

2-5-1, Shikada-cho, Okayama, 700-8558, Japan

TEL

086-235-7313

Email



Public contact

Name of contact person

1st name
Middle name
Last name Yasuaki Arai

Organization

JIVROSG, Coordinating Office

Division name

Division of Diagnostic Radiology, National Cancer Center Hospital

Zip code


Address

5-1-1, Tsukiji, Chu0-ku, Tokyo, 104-0045, Japan

TEL

03-3542-2511

Homepage URL

http://jivrosg.umin.jp/

Email

jivrosgoffice@ml.res.ncc.go.jp


Sponsor or person

Institute

Japan Interventional Radiology in Oncology Study Group (JIVROSG)

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 04 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 02 Month 29 Day

Date of IRB


Anticipated trial start date

2008 Year 04 Month 01 Day

Last follow-up date

2010 Year 08 Month 01 Day

Date of closure to data entry

2010 Year 08 Month 01 Day

Date trial data considered complete

2010 Year 08 Month 01 Day

Date analysis concluded

2010 Year 10 Month 01 Day


Other

Other related information



Management information

Registered date

2008 Year 04 Month 21 Day

Last modified on

2012 Year 03 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001371


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name